Cargando…
Composite active range of motion (CX(A)) and relationship with active function in upper and lower limb spastic paresis
OBJECTIVE: The aim of this study is to evaluate a novel composite measure of active range of motion (X(A)) and determine whether this measure correlates with active function. DESIGN: Post hoc analysis of two randomized, placebo-controlled, double-blind studies with open-label extensions exploring ch...
Autores principales: | Bayle, Nicolas, Maisonobe, Pascal, Raymond, Romain, Balcaitiene, Jovita, Gracies, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263039/ https://www.ncbi.nlm.nih.gov/pubmed/32336148 http://dx.doi.org/10.1177/0269215520911970 |
Ejemplares similares
-
Factors Influencing Goal Attainment in Patients with Post-Stroke Upper Limb Spasticity Following Treatment with Botulinum Toxin A in Real-Life Clinical Practice: Sub-Analyses from the Upper Limb International Spasticity (ULIS)-II Study
por: Fheodoroff, Klemens, et al.
Publicado: (2015) -
Effect of early use of AbobotulinumtoxinA after stroke on spasticity progression: Protocol for a randomised controlled pilot study in adult subjects with moderate to severe upper limb spasticity (ONTIME pilot)
por: Kong, Keng He, et al.
Publicado: (2017) -
Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)
por: Turner-Stokes, Lynne, et al.
Publicado: (2016) -
Guided Self-rehabilitation Contracts Combined With AbobotulinumtoxinA in Adults With Spastic Paresis
por: Gracies, Jean-Michel, et al.
Publicado: (2021) -
When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
por: Gracies, Jean-Michel, et al.
Publicado: (2020)